Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer's disease.
Erica S ModesteLingyan PingCaroline M WatsonDuc M DuongEric B DammerErik C B JohnsonBlaine R RobertsJames J LahAllan I LeveyNicholas T SeyfriedPublished in: Molecular neurodegeneration (2023)
Our findings provide insight into additional protein biomarkers and pathways reflecting underlying brain pathology that are shared or differ by race.